Log inSign up
user avatar
Radcliffe Cardiology
@radcliffeCARDIO
Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide.
Joined May 2009
19.9K
Following
23.1K
Followers
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    May 13, 2021
    Patient with NSTE-ACS, 70 yrs, no AF, planned PCI, low bleeding risk: what strategy would you choose? #NSTEMIRoundtable2021
    ASA + clopidogrel, 12mths21.9%
    ASA + prasugrel, 12 mths26.5%
    ASA + ticagrelor, 12 mths33.7%
    ASA + cangrelor, 12 mths17.9%
    7,259 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Jun 9, 2021
    Which statement best describes your attitude towards pre-treatment of NSTE-ACS, with a #P2Y12 inhibitor? #NSTEMIRoundtable2021
    Benefits outweigh risks23.3%
    Risky50.8%
    Not enough evidence25.9%
    5,670 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Jul 23, 2021
    Post-PCI, which stent optimisation feature are you least confident assessing? Learn more 👉 bit.ly/3ryWKyd
    Under-expansion20.3%
    Malapposition26.6%
    Tissue protrusion31.6%
    Dissection21.6%
    4,553 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Jul 20, 2021
    Which of the following presents the biggest challenge for your procedure planning, pre-PCI? Learn more 👉 bit.ly/3wPBzsn
    Lesion preparation25.3%
    Plaque distribution26.6%
    Stent sizing29%
    Stent optimisation19.1%
    5,013 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Aug 18, 2021
    What is the biggest barrier to adopting SGLT-2 inhibitors in your clinical practice? #heartfailure #esc2021 #ECSCongress @BiykemB @lamcardio
    Lack of experience22.4%
    Side effect concerns23.2%
    Pill burden23.3%
    Cost31.1%
    4,954 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    May 13, 2021
    Which approach do you most frequently use to guide DES implantation? Learn More 👉🏻 bit.ly/3w0ZO74
    High-res imaging44.5%
    Angiography55.5%
    1,523 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Nov 13, 2021
    How could AHA clinical trials impact current ESC guideline recommendations? #AHA21 👉USE #AHARME TO JOIN THE CONVERSATION 👈 Learn more about Heart Failure - bit.ly/3mKjKcA  ❌Not intended for US HCPs @GiuseppeGalati_ @ShelleyZieroth @ValleAlfonso @hvanspall
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Jun 15, 2021
    Which of the following #PCI complications do you worry about most? Learn More 👉🏻 bit.ly/3w0ZO74
    Medial dissection41.4%
    Malapposition31.6%
    Underexpansion27%
    1,712 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Nov 26, 2021
    What is the future importance of #EjectionFraction for therapy selection in #HeartFailure? Share your thoughts below! Click the link to join the discussion on latest #HF guidelines with @BiykemB @NMHheartdoc @ilppina & Dr Andrew Coats. 👇 bit.ly/3E23kCM
    Irreplaceable36.6%
    Important/not essential36.3%
    Non-essential27.2%
    2,030 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Dec 5, 2022
    Thank you for joining #PCRRME at #PCRLV. Check out our educational videos on REPAIR or REPLACE and REAL-WORLD data with @PhilippLurz @masitges @m_taramasso Access the videos here 👉 bit.ly/3EVItCE #cardiotwitter #LondonValves #cardioed #TMVR #TEER
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Nov 29, 2022
    Will transcatheter tricuspid valve repair become a first line option in severe tricuspid regurgitation over surgery? 👉USE #PCRRME TO JOIN👈 @PhilippLurz @masitges @m_taramasso #cardiotwitter #LondonValves #cardioed #TMVR #TEE
    Likely60.5%
    Unlikely39.5%
    501 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Nov 9, 2021
    Follow and join the conversation at #AHA21 with leading #HF specialists @GiuseppeGalati_ @ShelleyZieroth @ValleAlfonso @hvanspall  👉USE #AHARME TO JOIN👈 Learn more about Heart Failure -  ow.ly/E44F50GJ3Fs  ❌Not intended for US HCPs #cardiotwitter #cardiology
    00:00
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Jan 28, 2022
    49 yr female; #CKD (no T2DM); eGFR 30; on ARB. What do you treat with to prevent further decline? Join the conversation: bit.ly/3H9PLSZ #CardioTwitter #MedEd #Epeeps @kamleshkhunti @HeerspinkHiddo @ShelleyZieroth
    Dapagliflozin16.1%
    Canagliflozin27.6%
    Empagliflozin31.8%
    Other24.5%
    2,633 votesFinal results
  • user avatar
    Radcliffe Cardiology
    @radcliffeCARDIO
    Nov 26, 2022
    Valve repair or replacement: Does real-world evidence influence your treatment choice? 👉USE #PCRRME TO JOIN👈 @PhilippLurz @masitges @m_taramasso #cardiotwitter #LondonValves #cardioed #TMVR #PCRLV
    Yes66.7%
    No33.3%
    501 votesFinal results